FDA approves new diabetes treatment
In late September 2019, the U.S. Food and Drug Administration (FDA) approved a new oral treatment for type 2 diabetes. Novo Nordisk’s Rybelsus (semaglutide) helps improve adult patients’…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
